Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:actsOn |
opioid receptor agonist
|
| gptkbp:alternativeName |
PT-6295
PT6295 |
| gptkbp:CASNumber |
1353857-97-6
|
| gptkbp:clinicalTrialPhase |
preclinical
|
| gptkbp:developedBy |
PharmacoFore, Inc.
|
| gptkbp:hasMolecularFormula |
C27H32N4O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
PT 6295
|
| gptkbp:investigatedBy |
pain management
|
| gptkbp:molecularWeight |
460.57 g/mol
|
| gptkbp:PubChem_CID |
52921841
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:target |
gptkb:delta-opioid_receptor
gptkb:mu-opioid_receptor |
| gptkbp:therapeuticArea |
analgesia
|
| gptkbp:bfsParent |
gptkb:Third_Peak
|
| gptkbp:bfsLayer |
7
|